Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cuadrado-Tejedor, Mara; b; * | Ricobaraza, Anaa | Frechilla, Dianaa | Franco, Rafaela | Pérez-Mediavilla, Albertoa; c; 1 | Garcia-Osta, Anaa; 1
Affiliations: [a] Division of Neurosciences, CIMA, University of Navarra, Pamplona, Spain | [b] Department of Anatomy, Faculty of Medicine, University of Navarra, Pamplona, Spain | [c] Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Navarra, Pamplona, Spain
Correspondence: [*] Correspondence to: Mar Cuadrado-Tejedor, Division of Neurosciences, CIMA, University of Navarra, Avda. de Pío XII 55, 31008 Pamplona, Spain. Tel.: +34 948 194700; Fax: +34 948 194715; E-mail: mcuadrado@unav.es.
Note: [1] Both authors contributed equally to this work.
Abstract: The etiology of the more common (sporadic) forms of Alzheimer's disease (AD) remains unknown, although age is the most important risk factor. Nevertheless, interactions between environmental risk factors and genetic background may also influence the onset and progression of sporadic AD. Chronic stress, associated with altered memory and other neurological processes, is thought to influence the pathogenesis of AD. Hence, we evaluated the effect of unpredictable and consecutive chronic mild stressors on the onset of an AD-related pathology in the Tg2576 mouse line that overexpresses the human amyloid-β protein precursor with the Swedish mutation (hAβPPSwe). Two months after exposure to chronic mild stress, 4 month-old animals that normally display no pathological features of AD, not only expressed pathological markers but also experienced cognitive dysfunction in the Morris water maze test. These findings suggest that chronic mild stress accelerates the onset of cognitive impairment and produces an increase in hippocampal amyloid-β and phospho-tau levels on a background of AD susceptibility.
Keywords: Amyloid-β, cognitive impairment, GSK3β, stress, tau
DOI: 10.3233/JAD-2011-110572
Journal: Journal of Alzheimer's Disease, vol. 28, no. 3, pp. 567-578, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl